Congenital toxoplasmosis in the United Kingdom: to screen or not to screen?
The United Kingdom National Screening Committee recently reviewed the evidence for prenatal and neonatal screening for toxoplasma infection and concluded that there was insufficient evidence to recommend screening in the United Kingdom. This issue will need to be revisited as new information or treatments become available. In this paper, the extent to which the research evidence on toxoplasma infection meets the criteria that need to be fulfilled for the introduction of screening in the United Kingdom is reviewed.
Gilbert
R E
RE
Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, London, UK. r.gilbert@ich.ucl.ac.uk
Peckham
C S
CS
D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis*; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D008403:Mass Screening / Q000191:economics; D015997:Neonatal Screening / Q000191:economics; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy*; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis* / Q000628:therapy* / Q000635:transmission; D006113:United Kingdom